IBDEI0GL ; ; 09-AUG-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,21013,0)
 ;;=L03.325^^58^829^23
 ;;^UTILITY(U,$J,358.3,21013,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21013,1,3,0)
 ;;=3^Acute Lymphangitis of Perineum
 ;;^UTILITY(U,$J,358.3,21013,1,4,0)
 ;;=4^L03.325
 ;;^UTILITY(U,$J,358.3,21013,2)
 ;;=^5009059
 ;;^UTILITY(U,$J,358.3,21014,0)
 ;;=L03.326^^58^829^29
 ;;^UTILITY(U,$J,358.3,21014,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21014,1,3,0)
 ;;=3^Acute Lymphangitis of Umbilicus
 ;;^UTILITY(U,$J,358.3,21014,1,4,0)
 ;;=4^L03.326
 ;;^UTILITY(U,$J,358.3,21014,2)
 ;;=^5009060
 ;;^UTILITY(U,$J,358.3,21015,0)
 ;;=L03.329^^58^829^28
 ;;^UTILITY(U,$J,358.3,21015,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21015,1,3,0)
 ;;=3^Acute Lymphangitis of Trunk,Unspec
 ;;^UTILITY(U,$J,358.3,21015,1,4,0)
 ;;=4^L03.329
 ;;^UTILITY(U,$J,358.3,21015,2)
 ;;=^5009062
 ;;^UTILITY(U,$J,358.3,21016,0)
 ;;=L08.9^^58^829^167
 ;;^UTILITY(U,$J,358.3,21016,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21016,1,3,0)
 ;;=3^Local Infection of Skin/Subcutaneous Tissue,Unspec
 ;;^UTILITY(U,$J,358.3,21016,1,4,0)
 ;;=4^L08.9
 ;;^UTILITY(U,$J,358.3,21016,2)
 ;;=^5009082
 ;;^UTILITY(U,$J,358.3,21017,0)
 ;;=L11.0^^58^829^9
 ;;^UTILITY(U,$J,358.3,21017,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21017,1,3,0)
 ;;=3^Acquired Keratosis Follicularis
 ;;^UTILITY(U,$J,358.3,21017,1,4,0)
 ;;=4^L11.0
 ;;^UTILITY(U,$J,358.3,21017,2)
 ;;=^5009091
 ;;^UTILITY(U,$J,358.3,21018,0)
 ;;=L20.0^^58^829^90
 ;;^UTILITY(U,$J,358.3,21018,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21018,1,3,0)
 ;;=3^Besnier's Prurigo
 ;;^UTILITY(U,$J,358.3,21018,1,4,0)
 ;;=4^L20.0
 ;;^UTILITY(U,$J,358.3,21018,2)
 ;;=^5009107
 ;;^UTILITY(U,$J,358.3,21019,0)
 ;;=L20.81^^58^829^87
 ;;^UTILITY(U,$J,358.3,21019,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21019,1,3,0)
 ;;=3^Atopic Neurodermatitis
 ;;^UTILITY(U,$J,358.3,21019,1,4,0)
 ;;=4^L20.81
 ;;^UTILITY(U,$J,358.3,21019,2)
 ;;=^5009108
 ;;^UTILITY(U,$J,358.3,21020,0)
 ;;=L20.82^^58^829^150
 ;;^UTILITY(U,$J,358.3,21020,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21020,1,3,0)
 ;;=3^Flexural Eczema
 ;;^UTILITY(U,$J,358.3,21020,1,4,0)
 ;;=4^L20.82
 ;;^UTILITY(U,$J,358.3,21020,2)
 ;;=^5009109
 ;;^UTILITY(U,$J,358.3,21021,0)
 ;;=L20.84^^58^829^162
 ;;^UTILITY(U,$J,358.3,21021,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21021,1,3,0)
 ;;=3^Intrinsic Eczema
 ;;^UTILITY(U,$J,358.3,21021,1,4,0)
 ;;=4^L20.84
 ;;^UTILITY(U,$J,358.3,21021,2)
 ;;=^5009111
 ;;^UTILITY(U,$J,358.3,21022,0)
 ;;=L20.89^^58^829^85
 ;;^UTILITY(U,$J,358.3,21022,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21022,1,3,0)
 ;;=3^Atopic Dermatitis NEC
 ;;^UTILITY(U,$J,358.3,21022,1,4,0)
 ;;=4^L20.89
 ;;^UTILITY(U,$J,358.3,21022,2)
 ;;=^5009112
 ;;^UTILITY(U,$J,358.3,21023,0)
 ;;=L20.9^^58^829^86
 ;;^UTILITY(U,$J,358.3,21023,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21023,1,3,0)
 ;;=3^Atopic Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,21023,1,4,0)
 ;;=4^L20.9
 ;;^UTILITY(U,$J,358.3,21023,2)
 ;;=^5009113
 ;;^UTILITY(U,$J,358.3,21024,0)
 ;;=L21.8^^58^829^262
 ;;^UTILITY(U,$J,358.3,21024,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21024,1,3,0)
 ;;=3^Seborrheic Dermatitis NEC
 ;;^UTILITY(U,$J,358.3,21024,1,4,0)
 ;;=4^L21.8
 ;;^UTILITY(U,$J,358.3,21024,2)
 ;;=^303310
 ;;^UTILITY(U,$J,358.3,21025,0)
 ;;=L21.9^^58^829^263
 ;;^UTILITY(U,$J,358.3,21025,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21025,1,3,0)
 ;;=3^Seborrheic Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,21025,1,4,0)
 ;;=4^L21.9
 ;;^UTILITY(U,$J,358.3,21025,2)
 ;;=^188703
 ;;^UTILITY(U,$J,358.3,21026,0)
 ;;=L23.7^^58^829^30
 ;;^UTILITY(U,$J,358.3,21026,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21026,1,3,0)
 ;;=3^Allergic Contact Dermatitis d/t Plants
 ;;^UTILITY(U,$J,358.3,21026,1,4,0)
 ;;=4^L23.7
 ;;^UTILITY(U,$J,358.3,21026,2)
 ;;=^5009122
 ;;^UTILITY(U,$J,358.3,21027,0)
 ;;=L23.9^^58^829^31
 ;;^UTILITY(U,$J,358.3,21027,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21027,1,3,0)
 ;;=3^Allergic Contact Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,21027,1,4,0)
 ;;=4^L23.9
 ;;^UTILITY(U,$J,358.3,21027,2)
 ;;=^5009125
 ;;^UTILITY(U,$J,358.3,21028,0)
 ;;=L24.9^^58^829^163
 ;;^UTILITY(U,$J,358.3,21028,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21028,1,3,0)
 ;;=3^Irritant Contact Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,21028,1,4,0)
 ;;=4^L24.9
 ;;^UTILITY(U,$J,358.3,21028,2)
 ;;=^5009136
 ;;^UTILITY(U,$J,358.3,21029,0)
 ;;=L25.9^^58^829^115
 ;;^UTILITY(U,$J,358.3,21029,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21029,1,3,0)
 ;;=3^Contact Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,21029,1,4,0)
 ;;=4^L25.9
 ;;^UTILITY(U,$J,358.3,21029,2)
 ;;=^5133647
 ;;^UTILITY(U,$J,358.3,21030,0)
 ;;=L26.^^58^829^148
 ;;^UTILITY(U,$J,358.3,21030,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21030,1,3,0)
 ;;=3^Exfoliative Dermatitis
 ;;^UTILITY(U,$J,358.3,21030,1,4,0)
 ;;=4^L26.
 ;;^UTILITY(U,$J,358.3,21030,2)
 ;;=^263886
 ;;^UTILITY(U,$J,358.3,21031,0)
 ;;=L27.0^^58^829^265
 ;;^UTILITY(U,$J,358.3,21031,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21031,1,3,0)
 ;;=3^Skin Eruption d/t Drugs/Meds,Generalized
 ;;^UTILITY(U,$J,358.3,21031,1,4,0)
 ;;=4^L27.0
 ;;^UTILITY(U,$J,358.3,21031,2)
 ;;=^5009144
 ;;^UTILITY(U,$J,358.3,21032,0)
 ;;=L27.1^^58^829^266
 ;;^UTILITY(U,$J,358.3,21032,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21032,1,3,0)
 ;;=3^Skin Eruption d/t Drugs/Meds,Localized
 ;;^UTILITY(U,$J,358.3,21032,1,4,0)
 ;;=4^L27.1
 ;;^UTILITY(U,$J,358.3,21032,2)
 ;;=^5009145
 ;;^UTILITY(U,$J,358.3,21033,0)
 ;;=L29.0^^58^829^250
 ;;^UTILITY(U,$J,358.3,21033,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21033,1,3,0)
 ;;=3^Pruritus Ani
 ;;^UTILITY(U,$J,358.3,21033,1,4,0)
 ;;=4^L29.0
 ;;^UTILITY(U,$J,358.3,21033,2)
 ;;=^100061
 ;;^UTILITY(U,$J,358.3,21034,0)
 ;;=L29.9^^58^829^251
 ;;^UTILITY(U,$J,358.3,21034,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21034,1,3,0)
 ;;=3^Pruritus,Unspec
 ;;^UTILITY(U,$J,358.3,21034,1,4,0)
 ;;=4^L29.9
 ;;^UTILITY(U,$J,358.3,21034,2)
 ;;=^5009153
 ;;^UTILITY(U,$J,358.3,21035,0)
 ;;=L30.0^^58^829^232
 ;;^UTILITY(U,$J,358.3,21035,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21035,1,3,0)
 ;;=3^Nummular Dermatitis
 ;;^UTILITY(U,$J,358.3,21035,1,4,0)
 ;;=4^L30.0
 ;;^UTILITY(U,$J,358.3,21035,2)
 ;;=^186823
 ;;^UTILITY(U,$J,358.3,21036,0)
 ;;=L30.1^^58^829^140
 ;;^UTILITY(U,$J,358.3,21036,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21036,1,3,0)
 ;;=3^Dyshidrosis
 ;;^UTILITY(U,$J,358.3,21036,1,4,0)
 ;;=4^L30.1
 ;;^UTILITY(U,$J,358.3,21036,2)
 ;;=^5009154
 ;;^UTILITY(U,$J,358.3,21037,0)
 ;;=L30.2^^58^829^132
 ;;^UTILITY(U,$J,358.3,21037,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21037,1,3,0)
 ;;=3^Cutaneous Autosensitization
 ;;^UTILITY(U,$J,358.3,21037,1,4,0)
 ;;=4^L30.2
 ;;^UTILITY(U,$J,358.3,21037,2)
 ;;=^5009155
 ;;^UTILITY(U,$J,358.3,21038,0)
 ;;=L30.4^^58^829^144
 ;;^UTILITY(U,$J,358.3,21038,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21038,1,3,0)
 ;;=3^Erythema Intertrigo
 ;;^UTILITY(U,$J,358.3,21038,1,4,0)
 ;;=4^L30.4
 ;;^UTILITY(U,$J,358.3,21038,2)
 ;;=^5009157
 ;;^UTILITY(U,$J,358.3,21039,0)
 ;;=L30.8^^58^829^135
 ;;^UTILITY(U,$J,358.3,21039,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21039,1,3,0)
 ;;=3^Dermatitis NEC
 ;;^UTILITY(U,$J,358.3,21039,1,4,0)
 ;;=4^L30.8
 ;;^UTILITY(U,$J,358.3,21039,2)
 ;;=^5009158
 ;;^UTILITY(U,$J,358.3,21040,0)
 ;;=L30.9^^58^829^136
 ;;^UTILITY(U,$J,358.3,21040,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21040,1,3,0)
 ;;=3^Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,21040,1,4,0)
 ;;=4^L30.9
 ;;^UTILITY(U,$J,358.3,21040,2)
 ;;=^5009159
 ;;^UTILITY(U,$J,358.3,21041,0)
 ;;=L40.0^^58^829^253
 ;;^UTILITY(U,$J,358.3,21041,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21041,1,3,0)
 ;;=3^Psoriasis Vulgaris
 ;;^UTILITY(U,$J,358.3,21041,1,4,0)
 ;;=4^L40.0
 ;;^UTILITY(U,$J,358.3,21041,2)
 ;;=^5009160
 ;;^UTILITY(U,$J,358.3,21042,0)
 ;;=L40.1^^58^829^256
 ;;^UTILITY(U,$J,358.3,21042,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21042,1,3,0)
 ;;=3^Pustulosis Psoriasis,Generalized
 ;;^UTILITY(U,$J,358.3,21042,1,4,0)
 ;;=4^L40.1
 ;;^UTILITY(U,$J,358.3,21042,2)
 ;;=^5009161
 ;;^UTILITY(U,$J,358.3,21043,0)
 ;;=L40.2^^58^829^11
 ;;^UTILITY(U,$J,358.3,21043,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21043,1,3,0)
 ;;=3^Acrodermatitis Continua
 ;;^UTILITY(U,$J,358.3,21043,1,4,0)
 ;;=4^L40.2
 ;;^UTILITY(U,$J,358.3,21043,2)
 ;;=^5009162
 ;;^UTILITY(U,$J,358.3,21044,0)
 ;;=L40.3^^58^829^255
 ;;^UTILITY(U,$J,358.3,21044,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21044,1,3,0)
 ;;=3^Pustulosis Palmaris et Plantaris
 ;;^UTILITY(U,$J,358.3,21044,1,4,0)
 ;;=4^L40.3
 ;;^UTILITY(U,$J,358.3,21044,2)
 ;;=^5009163
 ;;^UTILITY(U,$J,358.3,21045,0)
 ;;=L40.4^^58^829^157
 ;;^UTILITY(U,$J,358.3,21045,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21045,1,3,0)
 ;;=3^Guttate Psoriasis
 ;;^UTILITY(U,$J,358.3,21045,1,4,0)
 ;;=4^L40.4
 ;;^UTILITY(U,$J,358.3,21045,2)
 ;;=^5009164
 ;;^UTILITY(U,$J,358.3,21046,0)
 ;;=L40.8^^58^829^252
 ;;^UTILITY(U,$J,358.3,21046,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21046,1,3,0)
 ;;=3^Psoriasis NEC
 ;;^UTILITY(U,$J,358.3,21046,1,4,0)
 ;;=4^L40.8
 ;;^UTILITY(U,$J,358.3,21046,2)
 ;;=^271917
 ;;^UTILITY(U,$J,358.3,21047,0)
 ;;=L40.9^^58^829^254
 ;;^UTILITY(U,$J,358.3,21047,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21047,1,3,0)
 ;;=3^Psoriasis,Unspec
 ;;^UTILITY(U,$J,358.3,21047,1,4,0)
 ;;=4^L40.9
 ;;^UTILITY(U,$J,358.3,21047,2)
 ;;=^5009171
 ;;^UTILITY(U,$J,358.3,21048,0)
 ;;=L50.9^^58^829^286
 ;;^UTILITY(U,$J,358.3,21048,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21048,1,3,0)
 ;;=3^Urticaria,Unspec
 ;;^UTILITY(U,$J,358.3,21048,1,4,0)
 ;;=4^L50.9
 ;;^UTILITY(U,$J,358.3,21048,2)
 ;;=^5009204
 ;;^UTILITY(U,$J,358.3,21049,0)
 ;;=L53.8^^58^829^147
 ;;^UTILITY(U,$J,358.3,21049,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,21049,1,3,0)
 ;;=3^Erythematous Conditions NEC
 ;;^UTILITY(U,$J,358.3,21049,1,4,0)
 ;;=4^L53.8
